Q.How is WAKIX thought to work?
A.
The mechanism of action of WAKIX in excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy is unclear; however, its efficacy could be mediated through its activity at histamine 3 (H3) receptors. Watch this video to understand how WAKIX is thought to work.
Q.What symptoms of narcolepsy does WAKIX treat?
A.
WAKIX is indicated for the treatment of EDS or cataplexy in adult patients with narcolepsy.
Q.Do patients have to have both EDS and cataplexy to take WAKIX?
A.
No, patients do not have to have both EDS and cataplexy to take WAKIX.
Q.Is WAKIX a stimulant?
A.
No, WAKIX is not a stimulant.
Q.Is WAKIX a controlled substance?
A.
No, WAKIX is not a controlled substance; it is the first and only FDA-approved nonscheduled treatment for EDS or cataplexy in narcolepsy.